Who owns SINGULAR GENOMICS SYSTEMS IN?
- Ticker: OMIC
- CUSIP Number: 82933r100
Tip: Access positions for across all investors
Analyze quarterly positions in Singular Genomics Systems In with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Singular Genomics Systems In stock
Who bought or sold SINGULAR GENOMICS SYSTEMS IN this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
Deerfield Management Company | 5.0M | $2.3M | 0% | Dec 2023 |
|
Arch Venture Corp | 3.8M | $1.7M | 0% | Dec 2023 |
|
UBS Group | 2.2M | $1.0M | 0% | Dec 2023 |
|
Perceptive Advisors | 2.1M | $979k | -10% | Dec 2023 |
|
FMR | 2.1M | $808k | 0% | Sep 2023 |
|
Vanguard Group | 1.9M | $862k | -1% | Dec 2023 |
|
Casdin Capital | 1.3M | $609k | 0% | Dec 2023 |
|
QVIDTVM Management | 1.2M | $453k | 100% | Sep 2023 |
|
Bank Of Montreal | 983k | $481k | 68% | Dec 2023 |
|
BlackRock | 866k | $330k | -1% | Sep 2023 |
|
OrbiMed Advisors | 541k | $249k | 0% | Dec 2023 |
|
Verition Fund Management | 475k | $181k | -1% | Sep 2023 |
|
Geode Capital Management | 461k | $176k | 10% | Sep 2023 |
|
Platinum Investment Mangement | 427k | $163k | -51% | Sep 2023 |
|
HighTower Advisors | 418k | $193k | 56% | Dec 2023 |
|
Tikvah Management | 317k | $121k | 0% | Sep 2023 |
|
Bridgeway Capital Management | 278k | $106k | 0% | Sep 2023 |
|
Triatomic Management | 195k | $74k | 0% | Sep 2023 |
|
Renaissance Technologies | 154k | $59k | 40% | Sep 2023 |
|
Christopher Weil & Company | 138k | $64k | 17% | Dec 2023 |
|
Squarepoint Ops | 120k | $55k | -11% | Dec 2023 |
|
Millennium Management | 118k | $54k | -83% | Dec 2023 |
|
State Street Corporation | 113k | $43k | -19% | Sep 2023 |
|
Northern Trust | 80k | $31k | 0% | Sep 2023 |
|
Jpmorgan Chase & Co | 52k | $24k | -16% | Dec 2023 |
|
Citadel Advisors | 47k | $22k | -34% | Dec 2023 |
|
Marino, Stram & Associates | 40k | $18k | 0% | Dec 2023 |
|
Tower Research Capital | 33k | $13k | 75% | Sep 2023 |
|
Cambridge Investment Research Advisors | 26k | $12k | 0% | Dec 2023 |
|
Bank of New York Mellon | 26k | $12k | 0% | Dec 2023 |
|
Goldman Sachs Group | 21k | $9.5k | 0% | Dec 2023 |
|
Engineers Gate Manager | 15k | $5.7k | 13% | Sep 2023 |
|
Bay Rivers Group | 14k | $6.4k | 0% | Dec 2023 |
|
Morgan Stanley | 14k | $5.3k | -79% | Sep 2023 |
|
Two Sigma Securities | 13k | $5.8k | 100% | Dec 2023 |
|
Barclays | 12k | $6.0k | 0% | Dec 2023 |
|
Bank of America Corporation | 11k | $4.9k | -29% | Dec 2023 |
|
Qube Research & Technologies | 9.2k | $3.5k | -89% | Sep 2023 |
|
Royal Bank of Canada | 2.8k | $0 | 9% | Dec 2023 |
|
Dagco | 1.7k | $782.000000 | 100% | Dec 2023 |
|
Rhumbline Advisers | 1.7k | $764.021400 | 0% | Dec 2023 |
|
Simplex Trading | 522.00 | $0 | 172% | Dec 2023 |
|
Wells Fargo & Company | 377.00 | $173.005300 | 6% | Dec 2023 |
|
Harbour Investments | 172.00 | $78.999600 | 0% | Dec 2023 |
|
Citigroup | 29.00 | $13.000700 | 0% | Dec 2023 |
|
Who sold out of Singular Genomics Systems In?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Coatue Management | Jun 2023 | 1.7M | $1.4M |
Acuitas Investments | Sep 2023 | 522k | $199k |
Jacobs Levy Equity Management | Sep 2023 | 359k | $137k |
Y-Intercept | Jun 2023 | 154k | $128k |
Susquehanna International | Jun 2023 | 108k | $90k |
Marquette Asset Management | Sep 2023 | 103k | $39k |
Old Mission Capital | Jun 2023 | 95k | $79k |
Ergoteles | Jun 2023 | 56k | $46k |
D. E. Shaw & Co | Sep 2023 | 51k | $20k |
Jane Street | Sep 2023 | 13k | $4.9k |